Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Chakravarthy

Showing results (1-10 of 323) with videos related to

Pageof 33
Sort By:
Ophthalmology|March 24, 2020
Does the Inhibition of Vacular Endothelial Growth Factor in Neovascular Age-Related Macular Degeneration Result in Macular Atrophy?Usha Chakravarthy
BMJ (Clinical Research Ed.)|June 12, 2010
Bevacizumab for the treatment of neovascular age related macular degenerationUsha Chakravarthy
BMJ (Clinical Research Ed.)|October 28, 2006
Age related macular degenerationUsha Chakravarthy
JAMA|August 12, 2020
Current Perspective on Age-Related Macular DegenerationUsha Chakravarthy, Tunde Peto
JAMA Ophthalmology|May 1, 2019
New Findings From Diabetic Retinopathy Clinical Research Retina Network Protocol V Confirm a Role for Focal Laser Photocoagulation or Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: New Is Not Always BestTunde Peto, Usha Chakravarthy
Current Eye Research|March 15, 2005
AMD and micronutrient antioxidantsRuth Hogg, Usha Chakravarthy
Ophthalmology. Retina|August 4, 2023
Counseling Patients about Rare but Serious Harms: The Importance of Absolute as well as Relative RisksBarnaby Reeves, Usha Chakravarthy
Current Opinion in Ophthalmology|May 5, 2005
Self-reported visual functioning and quality of life in age-related macular degenerationUsha Chakravarthy, Michael Stevenson
Therapeutic Advances in Chronic Disease|December 20, 2012
Age-related macular degeneration: current treatment and future optionsTanya Moutray, Usha Chakravarthy
Expert Review of Clinical Pharmacology|November 25, 2011
VEGF-targeted therapy and beyond: pharmacotherapy and emerging treatments in agerelated macular degenerationStuart J McGimpsey, Usha Chakravarthy
Pageof 33

Showing results (1-10 of 323) with videos related to

Sort By:
Pageof 33
Ophthalmology|March 24, 2020
Does the Inhibition of Vacular Endothelial Growth Factor in Neovascular Age-Related Macular Degeneration Result in Macular Atrophy?Usha Chakravarthy
BMJ (Clinical Research Ed.)|June 12, 2010
Bevacizumab for the treatment of neovascular age related macular degenerationUsha Chakravarthy
BMJ (Clinical Research Ed.)|October 28, 2006
Age related macular degenerationUsha Chakravarthy
JAMA|August 12, 2020
Current Perspective on Age-Related Macular DegenerationUsha Chakravarthy, Tunde Peto
JAMA Ophthalmology|May 1, 2019
New Findings From Diabetic Retinopathy Clinical Research Retina Network Protocol V Confirm a Role for Focal Laser Photocoagulation or Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: New Is Not Always BestTunde Peto, Usha Chakravarthy
Current Eye Research|March 15, 2005
AMD and micronutrient antioxidantsRuth Hogg, Usha Chakravarthy
Ophthalmology. Retina|August 4, 2023
Counseling Patients about Rare but Serious Harms: The Importance of Absolute as well as Relative RisksBarnaby Reeves, Usha Chakravarthy
Current Opinion in Ophthalmology|May 5, 2005
Self-reported visual functioning and quality of life in age-related macular degenerationUsha Chakravarthy, Michael Stevenson
Therapeutic Advances in Chronic Disease|December 20, 2012
Age-related macular degeneration: current treatment and future optionsTanya Moutray, Usha Chakravarthy
Expert Review of Clinical Pharmacology|November 25, 2011
VEGF-targeted therapy and beyond: pharmacotherapy and emerging treatments in agerelated macular degenerationStuart J McGimpsey, Usha Chakravarthy
Pageof 33